Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2025-04-28 00:00:00 ET · period of report 2025-04-24 · accession 0001104659-25-040237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-28 | 2025-04-24 | MBIO | Litchman Manuel MD | Pres, CEO, Interim CFO, Dir | F - Tax | $1.24 | -27 | 1,634 | -2% | -$33.48 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2025-04-24 | F | D | 27 | $1.24 | 1,634 | D | — | — | (F1) 27 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units. (F2) Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. |